naltrexone has been researched along with Acute Liver Injury, Drug-Induced in 19 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (5.26) | 18.7374 |
1990's | 2 (10.53) | 18.2507 |
2000's | 3 (15.79) | 29.6817 |
2010's | 12 (63.16) | 24.3611 |
2020's | 1 (5.26) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Ding, D; Fang, H; Kelly, R; Liu, Z; Shi, Q; Tong, W | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Ahmadian, S; Dehpour, AR; Ebrahim-Habibi, A; Kashani-Amin, E; Malek, MR; Shafizadeh, M | 1 |
Azar, MR; Cashman, JR | 1 |
Dehpou, AR; Dehpour, AR; Hassanzadeh, G; Moslehi, A; Nabavizadeh, F; Nahrevanian, H; Sohanaki, H; Tavanga, SM; Zekri, A | 1 |
Cheng, PY; Peng, YJ; Wang, CC; Wei, HP; Wu, ES; Yen, MH | 1 |
Garbutt, JC | 1 |
Clemens, MG; Day, SA; Lakner, AM; Moore, CC; Schrum, LW; Wu, ES; Yen, MH | 1 |
Bryant, K; Fiellin, DA; Goulet, JL; Justice, AC; McGinnis, KA; Sullivan, LE; Tate, JP; Tetrault, JM | 1 |
Henderson, RD; McCombe, PA | 1 |
Hong, JS; Ko, HC; Lu, RB; Tang, FI; Yen, MH | 1 |
Kim, A; Kornetsky, C; Sax, DS | 1 |
Hetrick, WP; Krutzik, MN; Martinazzi, VP; Rusu, L; Sandman, CA; Taylor, DV | 1 |
Mitchell, JE | 1 |
2 review(s) available for naltrexone and Acute Liver Injury, Drug-Induced
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Efficacy and tolerability of naltrexone in the management of alcohol dependence.
Topics: Alcohol Deterrents; Alcohol Drinking; Alcoholism; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Dose-Response Relationship, Drug; Humans; Naltrexone; Narcotic Antagonists; Nausea | 2010 |
17 other study(ies) available for naltrexone and Acute Liver Injury, Drug-Induced
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Models, Biological; Predictive Value of Tests | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Investigating the role of endogenous opioid system in chloroquine-induced phospholipidosis in rat liver by morphological, biochemical and molecular modelling studies.
Topics: Animals; Chemical and Drug Induced Liver Injury; Chloroquine; Disease Models, Animal; Fatty Liver; Glycine; Hippurates; Liver; Male; Molecular Docking Simulation; Molecular Dynamics Simulation; Naltrexone; Narcotic Antagonists; Opioid Peptides; Phospholipids; Rats; Receptors, Opioid, mu; Signal Transduction | 2020 |
Potent inhibition of alcohol self-administration in alcohol-preferring rats by a κ-opioid receptor antagonist.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Conditioning, Operant; Ethanol; Male; Morphinans; Naltrexone; Narcotic Antagonists; Rats; Rats, Inbred Strains; Self Administration; Thioamides | 2014 |
Naltrexone attenuates endoplasmic reticulum stress induced hepatic injury in mice.
Topics: Alanine Transaminase; Animals; Anti-Inflammatory Agents; Aspartate Aminotransferases; bcl-2-Associated X Protein; Biomarkers; Caspase 3; Chemical and Drug Induced Liver Injury; Cholesterol; Cytoprotection; Disease Models, Animal; Endoplasmic Reticulum; Endoplasmic Reticulum Stress; Fatty Liver; Liver; Liver Circulation; Male; Mice; Mice, Inbred C57BL; Naltrexone; Narcotic Antagonists; Non-alcoholic Fatty Liver Disease; Proto-Oncogene Proteins c-bcl-2; Triglycerides; Tumor Necrosis Factor-alpha; Tunicamycin | 2014 |
Naltrexone protects against lipopolysaccharide/D-galactosamine-induced hepatitis in mice.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents; Antioxidants; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Galactosamine; Lipopolysaccharides; Liver; Male; Mice; Mice, Inbred ICR; Naltrexone; Narcotic Antagonists; Neutrophils; Nitrates; Nitrites; Superoxides; Time Factors; Tumor Necrosis Factor-alpha | 2008 |
Opioid-like compound exerts anti-fibrotic activity via decreased hepatic stellate cell activation and inflammation.
Topics: Actins; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Proliferation; Cell Survival; Cells, Cultured; Chemical and Drug Induced Liver Injury; Collagen; Disease Models, Animal; Hepatic Stellate Cells; Immunoblotting; Liver Cirrhosis; Male; Matrix Metalloproteinase 13; Matrix Metalloproteinase 2; Morphinans; Naltrexone; Narcotic Antagonists; Rats; Rats, Inbred WKY; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction | 2011 |
Hepatic safety and antiretroviral effectiveness in HIV-infected patients receiving naltrexone.
Topics: Adult; Aged; Alanine Transaminase; Alcoholism; Antiretroviral Therapy, Highly Active; Aspartate Aminotransferases; CD4 Lymphocyte Count; Chemical and Drug Induced Liver Injury; Cohort Studies; Databases, Factual; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Female; HIV Infections; Humans; Liver; Liver Function Tests; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; RNA, Viral; Veterans | 2012 |
Riluzole: a glimmer of hope in the treatment of motor neurone disease.
Topics: Chemical and Drug Induced Liver Injury; Drug Interactions; Humans; Male; Middle Aged; Motor Neuron Disease; Naltrexone; Narcotic Antagonists; Neuroprotective Agents; Riluzole | 2005 |
Study of hepatotoxicity of naltrexone in the treatment of alcoholism.
Topics: Adolescent; Adult; Alanine Transaminase; Alcoholism; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Female; Humans; Liver; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Time Factors | 2006 |
Lack of hepatotoxicity with naltrexone treatment.
Topics: Adult; Aged; Aged, 80 and over; Alanine Transaminase; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Humans; Huntington Disease; Liver Function Tests; Middle Aged; Movement Disorders; Naltrexone | 1994 |
Naltrexone has no hepatotoxic effects in a self-injurious patient with chronic hepatitis.
Topics: Adult; Chemical and Drug Induced Liver Injury; Hepatitis, Viral, Human; Humans; Liver Function Tests; Male; Naltrexone; Self-Injurious Behavior | 1993 |
Naltrexone and hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Humans; Hyperphagia; Naltrexone | 1986 |